Table 2 Description of the sample of Dementia individuals in the clusters obtained.
From: Genetic-based patient stratification in Alzheimer’s disease
Variable | Cluster 1 | Cluster 2 | Cluster 3 | Statistic | p-value |
|---|---|---|---|---|---|
Number | 11 | 29 | 2 | NA | NA |
Sex (Female) | 5 (45.45%) | 11 (37.93%) | 1 (50.0%) | 0.27 | 0.8753 |
Education years | 14.82 ± 1.95 | 15.97 ± 2.85 | 13.50 ± 1.50 | 1.34 | 0.2739 |
Age | 70.91 ± 8.77 | 75.54 ± 8.50 | 85.25 ± 4.35 | 2.63 | 0.0852 |
APOE E2/E2 | 0 (0.0%) | 10 (34.48%) | 1 (50.0%) | 5.52 | 0.0633 |
APOE E2/E3 | 0 (0.0%) | 1 (3.45%) | 0 (0.0%) | 0.46 | 0.7948 |
APOE E3/E4 | 6 (54.55%) | 15 (51.72%) | 1 (50.0%) | 0.03 | 0.9850 |
APOE E4/E4 | 5 (45.45%) | 3 (10.34%) | 0 (0.0%) | 6.87 | 0.0322 |
Aβ(1–42) (pg/mL) | 677.29 ± 399.19 | 714.13 ± 313.29 | 499.55 ± 43.55 | 0.38 | 0.6875 |
tTau (pg/mL) | 439.24 ± 150.33 | 359.55 ± 101.03 | 262.7 ± 51.10 | 2.59 | 0.0889 |
pTau (pg/mL) | 44.17 ± 15.49 | 35.39 ± 11.58 | 26.06 ± 5.7 | 2.43 | 0.1022 |
AV45 | 1.39 ± 0.17 | 1.38 ± 0.23 | 1.34 ± 0.063 | 0.04 | 0.9617 |
FDG | 0.99 ± 0.12 | 1.02 ± 0.17 | 1.02 ± 0.08 | 0.10 | 0.9095 |
MRI WholeBrain | 0.6305 ± 0.0636 | 0.666 ± 0.0711 | 0.6573 ± 0.1054 | 0.91 | 0.4109 |
MRI Ventricles | 0.0257 ± 0.0101 | 0.0357 ± 0.0154 | 0.0195 ± 0.0000 | 2.28 | 0.1168 |
MRI MidTemp | 0.0109 ± 0.0024 | 0.0118 ± 0.0019 | 0.0121 ± 0.0016 | 0.81 | 0.4550 |
MRI Hippocampus | 0.0035 ± 0.0004 | 0.0038 ± 0.0007 | 0.0038 ± 0.0005 | 0.64 | 0.5348 |
MRI Fusiform | 0.0100 ± 0.0017 | 0.0108 ± 0.0016 | 0.0109 ± 0.0002 | 0.95 | 0.3958 |
MRI Entorhinal | 0.0017 ± 0.0003 | 0.0020 ± 0.0005 | 0.0023 ± 0.0002 | 2.18 | 0.1277 |
MMSE | 22.45 ± 1.72 | 22.90 ± 2.02 | 22.50 ± 0.50 | 0.22 | 0.8047 |
CDR-SOB | 5.45 ± 1.78 | 4.07 ± 1.42 | 4.25 ± 0.75 | 3.18 | 0.0523 |